Chanel La
Director of Product Development, EdiblesGreen Thumb Industries (GTI)Chanel La is the Director of Product Development, Edibles at Green Thumb Industries (GTI), where she leads high-impact teams to develop and scale cannabis-infused products with a focus on quality, compliance, and operational efficiency. With over 10 years of experience in the cannabis industry and a PhD in Chemistry, Chanel brings a rare combination of scientific expertise and proven leadership in cross-functional environments. At GTI, she has driven record-breaking product launches, streamlined development workflows, and built the infrastructure needed to accelerate innovation. She is passionate about mentoring teams and delivering exceptional products in one of the industry's most fast-evolving categories.
Delivery Matters: Engineering Bioavailability, Emulsions, and Precision Inhalation
How a cannabinoid enters the body shapes everything that follows. Route of administration drives onset time, bioavailability, dose consistency, and u
How a cannabinoid enters the body shapes everything that follows. Route of administration drives onset time, bioavailability, dose consistency, and ultimately whether patients stick with a product. An oral edible may take an hour to work and lose mu
How a cannabinoid enters the body shapes everything that follows. Route of administration drives onset time, bioavailability, dose consistency, and ultimately whether patients stick with a product. An oral edible may take an hour to work and lose much of its potency to first-pass metabolism. An inhaled dose hits in minutes but demands precision to stay reliable. Topicals and water-soluble emulsions open entirely new performance and credibility p
How a cannabinoid enters the body shapes everything that follows. Route of administration drives onset time, bioavailability, dose consistency, and ultimately whether patients stick with a product. An oral edible may take an hour to work and lose much of its potency to first-pass metabolism. An inhaled dose hits in minutes but demands precision to stay reliable. Topicals and water-soluble emulsions open entirely new performance and credibility profiles. For executives, product developers, and researchers, mastering these differences is now central to cannabis business growth strategies.
This session unpacks the formulation science separating ordinary products from clinically credible ones. We'll connect bioavailability, emulsion technology, and precision inhalation to current cannabis market trends and the cannabis innovation reshaping shelves and pipelines. The shift into precision formulation isn't just chemistry — it's one of the clearest cannabis industry opportunities for brands ready to lead.
